Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: A randomized controlled trial
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A relapse prevention program called the Information Technology Aided Relapse Prevention Programme in Schizophrenia (ITAREPS) has been developed and is reported to be highly effective. However the effectiveness was influenced by user adherence to the protocol of the program, the exact effectiveness and the role of the ITAREPS have been partially uncertain. OBJECTIVE: The purpose of this study is to evaluate the effectiveness of the ITAREPS excluding the effect of user adherence to the protocol of the program. METHOD: We attempted to perform a randomized controlled trial by the devised method with visiting nurse service. Outpatients with schizophrenia were randomized to the ITAREPS (n=22) or control group (n=23) and were observed for 12 months. RESULTS: The risk of rehospitalization was reduced in the ITAREPS group (2 [9.1%]) compared with the control group (8 [34.8%]) (hazard ratio=0.21, 95% CI 0.04-0.99, p=0.049; number needed to treat (NNT)=4, 95% CI 2.1-35.5). The mean number of inpatient days was significantly lower in the ITAREPS group (18.5 days) compared with the control group (88.8 days) (p=0.036). The ratio of the number of rehospitalizations to that of relapses was significantly lower (p=0.035) and the mean change in total BPRS scores at relapse from baseline was significantly less in the ITAREPS group (p=0.019). CONCLUSIONS: The relapse prevention effectiveness of the ITAREPS was high, and we confirmed that the ITAREPS, i.e., detecting signs of relapse and increasing medication during the warning state, is an effective intervention during the early stages of relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60239-6 · Cited by 931 · cited 1×
“Recent systematic reviews have shown that antipsychotic drug therapy can reduce the recurrence rate of schizophrenia (Leucht et al., 2012).”
BackgroundNatural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort
Wiersma, D., Nienhuis, F. J., Slooff, C. J., & Giel, R. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033315 · Cited by 649
Tiihonen, J., Haukka, J., Taylor, M., Haddad, P. M., Patel, M. X., & Korhonen, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10081224 · Cited by 619
Takeuchi, H., Suzuki, T., Uchida, H., Watanabe, K., & Mimura, M. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.021 · Cited by 115 · cited 1×
“However, this therapy is often interrupted because of patient compliance and side effects (Keith, 2006); antipsychotic drug therapy strategies for the maintenance phase of schizophrenia are not well established (Takeuchi et al., 2012).”
BackgroundMathalon, D. H., Sullivan, E. V., Lim, K. O., & Pfefferbaum, A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.148 · cited 1×
“Repeated relapses lead to worsening of prognosis, such as poorer responseto treatment (McGlashan, 1988), organic changes in thebrain(Mathalon et al., 2001),and increasedsuicide rate (Wiersma et al., 1998).”
Background
Cited by
Ben-Zeev, D., Scherer, E. A., Wang, R., Xie, H., & Campbell, A. T. (2015) · Psychiatric Rehabilitation Journal · doi:10.1037/prj0000130 · Cited by 429
Emerging mHealth and eHealth interventions for serious mental illness: a review of the literature
Naslund, J. A., Marsch, L. A., McHugo, G. J., & Bartels, S. J. (2015) · Journal of Mental Health · doi:10.3109/09638237.2015.1019054 · Cited by 327
“Among these were 4 modified versions of the Health Buddy automated home messaging device delivered across diverse mental health settings (Godleski et al., 2012; Kasckow et al., 2011; Pratt et al., 2013; Pratt et al., 2014), 3 separate evaluations of the Information Technology Aided Relapse Prevention Programme in Schi…”
Bell, I. H., Lim, M. H., Rossell, S. L., & Thomas, N. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600523 · Cited by 189
“Adherence to the monitoring protocol by patients and caregivers was relatively low in the two initial ITAREPS trials (50,51).”
BackgroundInfluentialAbaza, H., & Marschollek, M. (2017) · Methods of Information in Medicine · doi:10.3414/me17-05-0003 · Cited by 138
“In the ITAREPS study, schizophrenic patients were instructed to submit a weekly SMS questionnaire, and if any early warning signals were identified, the physician was notified by an email and accordingly the patient was contacted by phone to adjust the dose of antisychotic medications [111, 112, 113].”
MethodTechnology to assess and support self-management in serious mental illness
Depp, C. A., Moore, R. C., Perivoliotis, D., & Granholm, E. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.2/cdepp · Cited by 48
Metadata
- Authors
- Komatsu, H., Sekine, Y., Okamura, N., Kanahara, N., Okita, K., Matsubara, S., Hirata, T., Komiyama, T., Watanabe, H., Minabe, Y., & Iyo, M.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 150
- Issue
- 1
- Pages
- 240-244
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2110463354
- Cited by
- 37
- References
- 5
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: A randomized controlled trial. https://app.cochat.ai/papers/10.1016/j.schres.2013.08.007
- The paper
- Komatsu, H., Sekine, Y., Okamura, N., Kanahara, N., Okita, K., Matsubara, S., Hirata, T., Komiyama, T., Watanabe, H., Minabe, Y., & Iyo, M. (2013). Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: A randomized controlled trial. Schizophrenia Research. https://doi.org/10.1016/j.schres.2013.08.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.